Products for Research Use Only
RegisterLogin

BAT1006

CAT: 0804-HY-P991233Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P991233Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
BAT1006 is a monoclonal antibody targeting HER2 extracellular domain II with enhanced antibody-dependent cell-mediated cytotoxicity (ADCC) for the study of HER2-positive locally advanced/metastatic solid tumors. BAT1006 has an approximately 5-fold enhanced ADCC effect compared to pertuzumab and exhibits potent anti-tumor activity in the HER2-positive Calu-3 xenograft mouse model[1].
UNSPSC
12352203
Target
EGFR
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
[BAT1006]
References & Citations
[1]Xingxing Mei, et al. Abstract CT189: A phase I study of BAT1006, a novel anti-HER2 antibody, in patients with locally advanced/metastatic solid tumors. Cancer research. Cancer Res (2023) 83 (8_Supplement) : CT189.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2

Related Products

CatalogName
HY-P991335BAT6026
HY-P991416BAT5906

Alternative Products

CatalogName
T9901A-956-01BAT1006
PTX25924Anti-Human CD340/ERBB2/HER2/NEU (BAT1006)
HY286306-01Research Grade Anti-Human CD340/ERBB2/HER2/NEU (BAT1006)
A136334Anti-CD340/ERBB2/HER2/NEU (BAT1006) Biosimilar (Monoclonal, IgG)

Popular Products